Pfizer reported a drop in third-quarter profits Tuesday as lower sales of Covid-19 products more than offset gains in other medications.

Profits were $3.5 billion, down 21 percent from the year-ago period. Revenues dipped six percent to $16.7 billion.

The big US drugmaker, which has been navigating a significant drop in coronavirus-related revenues, pointed to lower Covid-19 infections across the United States and internationally, compared with the year-ago period.

Pfizer also experienced a 20-percent fall in its vaccine revenues after US officials in the Trump administration narrowed guidance for getting the jabs in the United States.

Under Health and Human Services Secretary Robert Kennedy, Trump’s administration has recommended that for people aged five through 64, only those with h

See Full Page